Mercy BioAnalytics
Pre-clinicalDevelops liquid biopsy diagnostics for early cancer detection using extracellular vesicle-based technology.
Founded
2018
Focus
Diagnostics
About
Develops liquid biopsy diagnostics for early cancer detection using extracellular vesicle-based technology.
Funding History
2Total raised: $46M
Series A$41MNorthpond VenturesSep 15, 2022
Seed$5MUndisclosedMar 15, 2021
Company Info
TypePrivate
Founded2018
LocationNatick, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile